Kintara Therapeutics Stock Price Prediction
| KTRA Stock | USD 0.14 0.01 5.38% |
Oversold Vs Overbought
59
Oversold | Overbought |
Kintara Therapeutics stock price prediction is an act of determining the future value of Kintara Therapeutics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Kintara Therapeutics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Kintara Therapeutics and does not consider all of the tangible or intangible factors available from Kintara Therapeutics' fundamental data. We analyze noise-free headlines and recent hype associated with Kintara Therapeutics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Kintara Therapeutics' stock price prediction:EPS Estimate Current Year (0.46) | EPS Estimate Next Year (0.38) | Wall Street Target Price 14 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Kintara Therapeutics based on different types of headlines from major news networks to social media. The Kintara stock price prediction module provides an analysis of price elasticity to changes in media outlook on Kintara Therapeutics over a specific investment horizon. Using Kintara Therapeutics hype-based prediction, you can estimate the value of Kintara Therapeutics from the perspective of Kintara Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in Kintara Therapeutics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Kintara Therapeutics to buy its stock at a price that has no basis in reality. In that case, they are not buying Kintara because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Kintara Therapeutics after-hype prediction price | USD 0.14 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Kintara |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kintara Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kintara Therapeutics After-Hype Price Prediction Density Analysis
As far as predicting the price of Kintara Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Kintara Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Kintara Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Kintara Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Kintara Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Kintara Therapeutics' historical news coverage. Kintara Therapeutics' after-hype downside and upside margins for the prediction period are 0.01 and 11.92, respectively. We have considered Kintara Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Kintara Therapeutics is dangerous at this time. Analysis and calculation of next after-hype price of Kintara Therapeutics is based on 3 months time horizon.
Kintara Therapeutics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Kintara Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Kintara Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Kintara Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.66 | 11.78 | 0.00 | 0.01 | 6 Events / Month | 17 Events / Month | In about 6 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.14 | 0.14 | 2.19 |
|
Kintara Therapeutics Hype Timeline
Kintara Therapeutics is now traded for 0.14. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.01. Kintara is projected to increase in value after the next headline, with the price projected to jump to 0.14 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 2.19%, whereas the daily expected return is now at 0.66%. The volatility of related hype on Kintara Therapeutics is about 56339.13%, with the expected price after the next announcement by competition of 0.15. The company currently holds 503 K in liabilities with Debt to Equity (D/E) ratio of 0.03, which may suggest the company is not taking enough advantage from borrowing. Given the investment horizon of 90 days the next projected press release will be in about 6 days. Check out Kintara Therapeutics Basic Forecasting Models to cross-verify your projections.Kintara Therapeutics Related Hype Analysis
Having access to credible news sources related to Kintara Therapeutics' direct competition is more important than ever and may enhance your ability to predict Kintara Therapeutics' future price movements. Getting to know how Kintara Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Kintara Therapeutics may potentially react to the hype associated with one of its peers.
Kintara Therapeutics Additional Predictive Modules
Most predictive techniques to examine Kintara price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kintara using various technical indicators. When you analyze Kintara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Kintara Therapeutics Predictive Indicators
The successful prediction of Kintara Therapeutics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Kintara Therapeutics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Kintara Therapeutics based on analysis of Kintara Therapeutics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Kintara Therapeutics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Kintara Therapeutics's related companies. | 2023 | 2024 (projected) | Payables Turnover | 0.0194 | 0.011 | Days Of Inventory On Hand | 3.1K | 2.7K |
Story Coverage note for Kintara Therapeutics
The number of cover stories for Kintara Therapeutics depends on current market conditions and Kintara Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Kintara Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Kintara Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Kintara Therapeutics Short Properties
Kintara Therapeutics' future price predictability will typically decrease when Kintara Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Kintara Therapeutics often depends not only on the future outlook of the potential Kintara Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Kintara Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.6 M | |
| Cash And Short Term Investments | 1.5 M |
Check out Kintara Therapeutics Basic Forecasting Models to cross-verify your projections. For information on how to trade Kintara Stock refer to our How to Trade Kintara Stock guide.You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Complementary Tools for Kintara Stock analysis
When running Kintara Therapeutics' price analysis, check to measure Kintara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kintara Therapeutics is operating at the current time. Most of Kintara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kintara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kintara Therapeutics' price. Additionally, you may evaluate how the addition of Kintara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |
Is Kintara Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kintara Therapeutics. If investors know Kintara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kintara Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.22) | Return On Assets (1.13) | Return On Equity (3.29) |
The market value of Kintara Therapeutics is measured differently than its book value, which is the value of Kintara that is recorded on the company's balance sheet. Investors also form their own opinion of Kintara Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Kintara Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kintara Therapeutics' market value can be influenced by many factors that don't directly affect Kintara Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kintara Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kintara Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kintara Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.